IBLHL · IBL HealthCare Limited
Financial Results for the Year Ended June 30, 2026
- Filed
- 23 September 2026 at 1:55 pm
- Category
- Financials
- Sentiment
- Neutral
- Impact
- Medium
AI executive summary
IBL HealthCare Limited reported its annual financial results for the year ended June 30, 2026, showing revenue of PKR 4,607,109 thousand and a net profit after tax of PKR 220,402 thousand (EPS of PKR 2.24). The board of directors has recommended no dividend for the year.
Key takeaways
- Revenue from contracts with customers rose to PKR 4,607,109 thousand for the year ended June 30, 2026, compared to PKR 4,322,471 thousand in the previous year.
- Profit after taxation for the year increased to PKR 220,402 thousand compared to PKR 208,371 thousand in FY2025.
- Basic and diluted earnings per share (EPS) stood at PKR 2.24 for 2026 compared to restated PKR 2.11 for 2025.
- Pre-tax profit increased to PKR 401,256 thousand compared to PKR 340,212 thousand in the prior year.
- The board of directors has recommended nil cash dividend, nil bonus shares, and nil right shares for the year ended June 30, 2026.
Filing details
Financial results
Annual · Unaudited · Standalone · 30 June 2026
Figures in Rupees in '000
Reporting period
Year
- Income
- 4,607,109 (prior 4,322,471)
- Profit after tax
- 220,402 (prior 208,371)
- EPS
- 2.24 (prior 2.11)
Dividend and entitlement
- Type
- None
- Notes
- No cash dividend, bonus shares, or right shares were declared (all stated as NIL).
- #financial-results
- #annual-results
- #earnings
- #iblhl
This summary is AI-generated and may contain errors or omissions. Review the official PSX filing before making an investment decision.